Home
Our Pipeline
Clinical Trials
CB-24 Mode of Action
Scientific Reviews
Press Release
The Team
Contact Us

Investor Relations

Reach Us



Our Office

38/39 Fitzwilliam Square West Dublin 2, D02 NX53, Ireland.



Email

info@celticbiotech.com

A clinical-stage biopharmaceutical company developing first-in-class venom-derived peptide therapies to transform patient outcomes.

Follow
Follow

COMPANY

Our Pipeline

Clinical Trials

CB-24 Mode of Action

Scientific Reviews

The Team

INVESTORS

Investor Relations

Press Release

Events

CONTACT

Get in Touch

A clinical-stage biopharmaceutical company developing first-in-class venom-derived peptide therapies to transform patient outcomes.

Follow
Follow

COMPANY

Clinical Trials

Our Pipeline

CB-24 Mode of Action

Scientific Reviews

The Team

INVESTORS

Investor Relations

Press Release

Events

CONTACT

Get in Touch

© 2026 Celtic Biotech. All rights reserved.

Privacy Policy